Laetitia leads our efforts on vaccines policy and advocacy to encourage pharmaceutical innovation and improve people’s health and well-being around the world.
She oversees the Vaccines Committee, the interface between IFPMA members and international public health organizations involved in global immunization, which promotes sustainable policies and initiatives to support vaccine innovation and access to vaccines globally.
Prior to joining IFPMA, Laetitia worked as a clinical research associate for the multidisciplinary center on oncology at the University Hospital Lausanne.
She has a PhD in Molecular Biology from the University of Lausanne, Switzerland.
The COVID-19 pandemic has shown that, when we work together, we can achieve more than we ever thought possible. Together, we can give vaccines the greatest chance to make an even greater impact on our health, our communities, and our world.
More from Laetitia
Global resilience and national security starts with preventing ill health
Prevention is a necessity government must invest in to secure a stable and prosperous future for everyone.
Read more
The power of vaccines to reduce the impact of chronic diseases
Chronic diseases are on the rise. Vaccines can help reduce the impact on people, health systems and society. This year’s UN High-level Meeting on NCDs and Mental Health provides an opportunity to maximise vaccine benefits. Non-communicable diseases (NCDs), such as cancer, cardiovascular disease, chronic respiratory diseases and diabetes, are the leading cause of ill health...
Read more
Unlocking the full value of life-course immunization: A key to sustainable healthcare
An aging population, the rise of antimicrobial resistance, and the ongoing threat of infectious and chronic diseases are placing immense pressure on our societies. In this context, a paradigm shift from healthcare systems that focus on treating people when they are sick, to a prevention approach is a necessity to guarantee the efficiency and long-term...
Read more